These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Reduced susceptibility of Candida albicans clinical isolates to azoles and detection of mutations in the ERG11 gene. Zhang L, Yang HF, Liu YY, Xu XH, Ye Y, Li JB. Diagn Microbiol Infect Dis; 2013 Dec; 77(4):327-9. PubMed ID: 24070847 [Abstract] [Full Text] [Related]
6. Caspofungin activity against clinical isolates of azole cross-resistant Candida glabrata overexpressing efflux pump genes. Posteraro B, Sanguinetti M, Fiori B, La Sorda M, Spanu T, Sanglard D, Fadda G. J Antimicrob Chemother; 2006 Aug; 58(2):458-61. PubMed ID: 16757500 [Abstract] [Full Text] [Related]
7. Susceptibility of Candida albicans to common and novel antifungal drugs, and relationship between the mating type locus and resistance, in Lebanese hospital isolates. Basma R, Barada G, Ojaimi N, Khalaf RA. Mycoses; 2009 Mar; 52(2):141-8. PubMed ID: 18627469 [Abstract] [Full Text] [Related]
9. Genetic relatedness and antifungal susceptibility profile of Candida albicans isolates from fungaemia patients. Costa-de-Oliveira S, Sousa I, Correia A, Sampaio P, Pais C, Rodrigues AG, Pina-Vaz C. Med Mycol; 2011 Apr; 49(3):248-52. PubMed ID: 20735323 [Abstract] [Full Text] [Related]
11. Antifungal susceptibilities of clinical isolates of Candida species, Cryptococcus neoformans, and Aspergillus species from Taiwan: surveillance of multicenter antimicrobial resistance in Taiwan program data from 2003. Hsueh PR, Lau YJ, Chuang YC, Wan JH, Huang WK, Shyr JM, Yan JJ, Yu KW, Wu JJ, Ko WC, Yang YC, Liu YC, Teng LJ, Liu CY, Luh KT. Antimicrob Agents Chemother; 2005 Feb; 49(2):512-7. PubMed ID: 15673726 [Abstract] [Full Text] [Related]
12. [Candida albicans resistance and genotyping by randomly amplified polymorphic DNA method]. Qian J, Zha GZ, Yu P. Hunan Yi Ke Da Xue Xue Bao; 2000 Aug 28; 25(4):327-30. PubMed ID: 12205990 [Abstract] [Full Text] [Related]
13. Anti-candidal activity of essential oils alone and in combination with amphotericin B or fluconazole against multi-drug resistant isolates of Candida albicans. Khan MS, Malik A, Ahmad I. Med Mycol; 2012 Jan 28; 50(1):33-42. PubMed ID: 21756200 [Abstract] [Full Text] [Related]
19. Molecular analysis and dimorphism of azole-susceptible and resistant Candida albicans isolates. Costa CR, Hasimoto e Souza LK, Ataídes FS, Ferri PH, Costa MP, Fernanades Ode F, Silva Mdo R. Rev Soc Bras Med Trop; 2011 Sep 28; 44(6):740-4. PubMed ID: 22094708 [Abstract] [Full Text] [Related]
20. In vitro susceptibility testing of Candida and Aspergillus spp. to voriconazole and other antifungal agents using Etest: results of a French multicentre study. Mallié M, Bastide JM, Blancard A, Bonnin A, Bretagne S, Cambon M, Chandenier J, Chauveau V, Couprie B, Datry A, Feuilhade M, Grillot R, Guiguen C, Lavarde V, Letscher V, Linas MD, Michel A, Morin O, Paugam A, Piens MA, Raberin H, Tissot E, Toubas D, Wade A. Int J Antimicrob Agents; 2005 Apr 28; 25(4):321-8. PubMed ID: 15784312 [Abstract] [Full Text] [Related] Page: [Next] [New Search]